Singapore markets close in 3 hours 51 minutes

Kronos Bio, Inc. (KRON)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.7300+0.1500 (+4.19%)
At close: 04:00PM EDT
3.7300 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 199.83M
Enterprise value -35.10M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.68
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.21

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-82.20%
S&P500 52-week change 3-13.66%
52-week high 321.5800
52-week low 32.9600
50-day moving average 34.5511
200-day moving average 36.4519

Share statistics

Avg vol (3-month) 3238.21k
Avg vol (10-day) 3173.95k
Shares outstanding 556.77M
Implied shares outstanding 6N/A
Float 843.31M
% held by insiders 115.53%
% held by institutions 162.92%
Shares short (30 Aug 2022) 43.53M
Short ratio (30 Aug 2022) 412.31
Short % of float (30 Aug 2022) 48.41%
Short % of shares outstanding (30 Aug 2022) 46.22%
Shares short (prior month 28 Jul 2022) 43.52M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-25.52%
Return on equity (ttm)-46.10%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -163.78M
Net income avi to common (ttm)-165.1M
Diluted EPS (ttm)-2.9230
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)267.89M
Total cash per share (mrq)4.72
Total debt (mrq)32.96M
Total debt/equity (mrq)11.28
Current ratio (mrq)15.07
Book value per share (mrq)5.20

Cash flow statement

Operating cash flow (ttm)-124.67M
Levered free cash flow (ttm)-68.74M